Table 4.

Level of cytokines in bronchoalveolar lavage fluid.

Marker	Treatment	Exposure duration (days)
		1	4	8	15	30
IFN-γ (pg/ml)	Air	1.79 ± 0.34	1.69 ± 0.15	1.62 ± 0.20	1.78 ± 0.15	1.59 ± 0.11
	ABS	3.11 ± 0.62*	2.61 ± 0.48*	2.18 ± 0.20	2.35 ± 0.09	2.13 ± 0.19
IL-10 (pg/ml)	Air	1.79 ± 0.25	2.05 ± 0.18	2.24 ± 0.16	2.14 ± 0.12	2.25 ± 0.11
	ABS	2.37 ± 0.13*	2.53 ± 0.21 *	2.57 ± 0.12	2.99 ± 0.10*	2.54 ± 0.15
IL-1β (pg/ml)	Air	4.69 ± 0.30	6.04 ± 1.09	6.40 ± 1.14	5.95 ± 0.57	5.28 ± 0.39
	ABS	4.78 ± 0.42	5.58 ± 0.65	6.60 ± 0.88	6.29 ± 0.35	5.76 ± 0.38
IL-4 (pg/ml)	Air	0.43 ± 0.06	0.47 ± 0.05	0.46 ± 0.03	0.43 ± 0.05	0.51 ± 0.04
	ABS	0.37 ± 0.03	0.43 ± 0.06	0.44 ± 0.04	0.53 ± 0.02	0.48 ± 0.05
IL-5 (pg/ml)	Air	5.98 ± 0.68	6.64 ± 0.93	6.62 ± 0.72	6.46 ± 0.71	6.49 ± 0.45
	ABS	6.01 ± 0.32	6.73 ± 0.57	7.03 ± 0.27	7.72 ± 0.44	7.65 ± 0.58
IL-6 (pg/ml)	Air	80.67 ± 8.91	102.00 ± 7.17	93.59 ± 7.08	111.58 ± 8.93	104.58 ± 8.64
	ABS	91.11 ± 4.73	104.56 ± 11	99.90 ± 3.18	104.62 ± 5.38	105.68 ± 8.56
KC (pg/ml)	Air	89.23 ± 15.6	114.62 ± 25	107.37 ± 15.34	140.42 ± 24.97	141.61 ± 28.79
	ABS	64.82 ± 6.05	80.75 ± 4.53	134.49 ± 24.14	127.99 ± 8.57	113.25 ± 7.84
TNF-α (pg/ml)	Air	1.57 ± 0.17	1.74 ± 0.48	1.95 ± 0.34	1.94 ± 0.29	1.54 ± 0.17
	ABS	2.02 ± 0.21	1.40 ± 0.10	1.80 ± 0.32	1.63 ± 0.21	1.40 ± 0.13

Values represents means ± SEMs; n = 8/group/time point.

^*p < 0.05 versus air-control group.